Membrane type-1 matrix metalloprotein inhibitors and uses thereof

Details for Australian Patent Application No. 2009327267 (hide)

Owner Universite du Quebec a Montreal

Inventors Beliveau, Richard; Gingras, Denis; Nyalendo, Carine

Agent Pizzeys

Pub. Number AU-A-2009327267

PCT Pub. Number WO2010/069074

Priority 61/138,375 17.12.08 US

Filing date 17 December 2009

Wipo publication date 24 June 2010

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 38/57 (2006.01) Medicinal preparations containing peptides

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/069074 Priority application(s): WO2010/069074

21 July 2011 Alteration of Name

  The name of the applicant has been altered to AngioChem, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009327268-Demulsifying of hydrocarbon feeds

2009327266-Combination of photodynamic therapy and anti-VEGF agents in the treatment of unwanted choroidal neovasculature